Related Experiment Video
Updated: Nov 19, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
544
Microstructural Tissue Changes in Alzheimer Disease Brains: Insights from Magnetization Transfer Imaging
I Colonna1, M Koini1, L Pirpamer1
1From the Department of Neurology (I.C., M.K., L.P., A.D., P.S., C.E., R.S., S.R.).
AJNR. American Journal of Neuroradiology
|January 29, 2021
Summary
Magnetization transfer ratio (MTR) reductions indicate brain damage in Alzheimer disease (AD). Lower MTR in gray and white matter regions is linked to cognitive decline, independent of atrophy and white matter damage.
Area of Science:
- Neuroimaging
- Neurology
- Biomarkers
Background:
- Reductions in Magnetization Transfer Ratio (MTR) are linked to microstructural damage in the brain.
- Alzheimer disease (AD) is characterized by progressive neurodegeneration and cognitive impairment.
Purpose of the Study:
- To compare MTR in gray matter (GM) and white matter (WM) between AD patients and healthy controls.
- To investigate the relationship between MTR and cognitive function in individuals with AD.
Main Methods:
- Prospective study involving 77 AD patients and 77 age-matched healthy controls.
- 3T MR imaging was used to determine MTR in various brain regions, including cortex, AD-signature regions, normal-appearing WM, and WM hyperintensities.
Main Results:
- MTR values were significantly lower in AD patients compared to controls across all investigated regions.
- Lower MTR in the cortex, AD-signature regions, normal-appearing WM, and WM hyperintensities were independent predictors of AD.
- Adjusting for atrophy and WM hyperintensities, lower GM MTR correlated with poorer cognitive functions, including global cognition, language, and constructional praxis.
Conclusions:
- Alzheimer disease is associated with reduced MTR in both GM and WM brain regions.
- Decreased MTR in cortical and AD-signature regions contributes to cognitive impairment, irrespective of brain atrophy and WM damage.
Related Concept Videos
Alzheimer's Disease: Overview
1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Magnetic Resonance Imaging
8.5K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
8.5K

